Jan Bolinder

About me
Publications
CV
Public outreach and news

About me

Professor of Clinical Diabetes Research at the Department of Medicine, Huddinge since 2005.

Research

Diabetes is one of our greatest public health problems, primarily because of the dramatic increase in type 2 diabetes, also known as age-related diabetes which now represents a global threat to human health.

Using microdialysis technology, the research group is investigating how the release of fatty acids is regulated in adipose tissue and muscle, and what significance this has for the development of insulin resistance and type 2 diabetes. In clinical studies, novel diabetes therapies and techniques for continuous glucose monitoring are evaluated in different collaborative projects. Incidence of diabetes and diabetic complications are studied in the Diabetes Incidence Study in Sweden (DISS).

Articles

Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2022;24(S1):S35-S57

New Insulins, Biosimilars, and Insulin Therapy.

Danne T; Heinemann L; Bolinder J
Article: DIABETOLOGIA. 2021;64(7):1595-1603

Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls.

Nathanson D; Svensson A-M; Miftaraj M; Franzén S; Bolinder J; Eeg-Olofsson K
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2021;23(S2):S46-S68

New Insulins, Biosimilars, and Insulin Therapy.

Danne T; Heinemann L; Bolinder J
Article: DIABETES OBESITY & METABOLISM. 2021;23(2):619-630

The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5).

Ólafsdóttir AF; Bolinder J; Heise T; Polonsky W; Ekelund M; Wijkman M; Pivodic A; Ahlén E; Schwarcz E; Nyström T; Hellman J; Hirsch IB; Lind M
Article: DIABETES CARE. 2021;44(1):141-149

Sustained Intensive Treatment and Long-term Effects on HbA1c Reduction (SILVER Study) by CGM in People With Type 1 Diabetes Treated With MDI.

Lind M; Ólafsdóttir AF; Hirsch IB; Bolinder J; Dahlqvist S; Pivodic A; Hellman J; Wijkman M; Schwarcz E; Albrektsson H; Heise T; Polonsky W
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2019;21(S1):S57-S78

New Insulins, Biosimilars, and Insulin Therapy.

Danne T; Heinemann L; Bolinder J
Article: DIABETIC MEDICINE. 2018;35(4):491-494

Could FreeStyle Libre™ sensor glucose data support decisions for safe driving?

Rayman G; Kröger J; Bolinder J
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2018;20(4):274-284

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).

Ólafsdóttir AF; Polonsky W; Bolinder J; Hirsch IB; Dahlqvist S; Wedel H; Nyström T; Wijkman M; Schwarcz E; Hellman J; Heise T; Lind M
Article: DIABETOLOGIA. 2018;61(3):539-550

Impact of flash glucose monitoring on hypoglycaemia in adults with type 1 diabetes managed with multiple daily injection therapy: a pre-specified subgroup analysis of the IMPACT randomised controlled trial.

Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R; Bolinder J
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2018;20(S1):S55-S70

New Insulins, Biosimilars, and Insulin Therapy.

Danne T; Heinemann L; Bolinder J
Article: DIABETES RESEARCH AND CLINICAL PRACTICE. 2017;133:21-29

Overweight, hyperglycemia and tobacco use are modifiable risk factors for onset of retinopathy 9 and 17years after the diagnosis of diabetes - A retrospective observational nation-wide cohort study.

Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW; Svensson MK
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2017;19(S1):S42-S58

New Insulins, Biosimilars, and Insulin Therapy.

Danne T; Heinemann L; Bolinder J
Article: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. 2017;317(4):379-387

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.

Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
Article: LANCET. 2016;388(10057):2254-2263

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial.

Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kröger J; Weitgasser R
Article: JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2016;10(3):754-761

Design and Methods of a Randomized Trial of Continuous Glucose Monitoring in Persons With Type 1 Diabetes With Impaired Glycemic Control Treated With Multiple Daily Insulin Injections (GOLD Study).

Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Pehrsson N-G; Moström P
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2016;18 Suppl 1:S43-S55

New Insulins, Biosimilars, and Insulin Therapy.

Danne T; Heinemann L; Bolinder J
Article: ACTA DIABETOLOGICA. 2015;52(3):581-589

Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors.

Anderbro T; Gonder-Frederick L; Bolinder J; Lins P-E; Wredling R; Moberg E; Lisspers J; Johansson U-B
Article: DIABETES-METABOLISM RESEARCH AND REVIEWS. 2015;31(2):138-146

The risk for diabetic nephropathy is low in young adults in a 17-year follow-up from the Diabetes Incidence Study in Sweden (DISS). Older age and higher BMI at diabetes onset can be important risk factors.

Svensson MK; Tyrberg M; Nyström L; Arnqvist HJ; Bolinder J; Östman J; Gudbjörnsdottir S; Landin-Olsson M; Eriksson JW
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2015;17 Suppl 1:S39-S46

New insulins and insulin therapy.

Bolinder J; Danne T
Article: ACTA DIABETOLOGICA. 2014;51(5):845-851

Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study.

Hommel E; Olsen B; Battelino T; Conget I; Schütz-Fuhrmann I; Hoogma R; Schierloh U; Sulli N; Gough H; Castañeda J; de Portu S; Bolinder J; SWITCH Study Group
Article: DIABETOLOGIA. 2014;57(7):1375-1381

The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods.

Rawshani A; Landin-Olsson M; Svensson A-M; Nyström L; Arnqvist HJ; Bolinder J; Gudbjörnsdottir S
Article: DIABETES OBESITY & METABOLISM. 2014;16(2):159-169

Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.

Bolinder J; Ljunggren Ö; Johansson L; Wilding J; Langkilde AM; Sjöström CD; Sugg J; Parikh S
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2014;16 Suppl 1:S34-S43

New insulins and insulin therapy.

Danne T; Bolinder J
Article: JOURNAL OF INTERNAL MEDICINE. 2014;275(1):39-48

Assessment of beta-cell function in young patients with type 2 diabetes: arginine-stimulated insulin secretion may reflect beta-cell reserve.

Sjostrand M; Carlson K; Arnqvist HJ; Gudbjörnsdottir S; Landin-Olsson M; Lindmark S; Nyström L; Svensson MK; Eriksson JW; Bolinder J
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2013;15 Suppl 1:S40-S47

New insulins and insulin therapy.

Danne T; Bolinder J
Article: DIABETOLOGIA. 2012;55(12):3155-3162

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial.

Battelino T; Conget I; Olsen B; Schütz-Fuhrmann I; Hommel E; Hoogma R; Schierloh U; Sulli N; Bolinder J; SWITCH Study Group
Article: DIABETES OBESITY & METABOLISM. 2012;14(11):990-999

Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metformin.

Ljunggren Ö; Bolinder J; Johansson L; Wilding J; Langkilde AM; Sjöström CD; Sugg J; Parikh S
Article: JOURNAL OF INTERNAL MEDICINE. 2012;271(4):414-420

Adipose zinc-α2-glycoprotein is a catabolic marker in cancer and noncancerous states.

Rydén M; Agustsson T; Andersson J; Bolinder J; Toft E; Arner P
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2012;97(3):1020-1031

Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin.

Bolinder J; Ljunggren Ö; Kullberg J; Johansson L; Wilding J; Langkilde AM; Sugg J; Parikh S
Article: DIABETES CARE. 2011;34(4):795-800

Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes.

Battelino T; Phillip M; Bratina N; Nimri R; Oskarsson P; Bolinder J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2011;96(4):1085-1092

Prolonged exercise-induced stimulation of skeletal muscle glucose uptake is due to sustained increases in tissue perfusion and fractional glucose extraction.

Hamrin K; Qvisth V; Hagström-Toft E; Enoksson S; Henriksson J; Bolinder J
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2011;(170):26-30

New insulins and insulin therapy.

Danne T; Bolinder J
Article: DIABETIC MEDICINE. 2011;28(2):156-161

Proinsulin/C-peptide ratio, glucagon and remission in new-onset Type 1 diabetes mellitus in young adults.

Schölin A; Nyström L; Arnqvist H; Bolinder J; Björk E; Berne C; Karlsson FA; Diabetes Incidence Study Group in Sweden (DISS)
Article: DIABETES TECHNOLOGY & THERAPEUTICS. 2011;13(1):49-54

The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy.

Conget I; Battelino T; Giménez M; Gough H; Castañeda J; Bolinder J; SWITCH Study Group
Article: DIABETIC MEDICINE. 2010;27(10):1151-1158

Fear of hypoglycaemia in adults with Type 1 diabetes.

Anderbro T; Amsberg S; Adamson U; Bolinder J; Lins P-E; Wredling R; Moberg E; Lisspers J; Johansson U-B
Article: DIABETOLOGIA. 2010;53(6):1084-1092

Long-term detrimental consequences of the onset of type 1 diabetes on annual earnings--evidence from annual registry data in 1990-2005.

Steen Carlsson K; Landin-Olsson M; Nyström L; Arnqvist HJ; Bolinder J; Ostman J; Gudbjörnsdóttir S
Article: INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, SUPPLEMENT. 2010;(166):1-10

Self-monitoring of blood glucose.

Garg S; Hirsch IB
Article: DIABETOLOGIA. 2008;51(12):2224-2232

Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15-34 years) but not in middle-aged (40-59 years) diabetic patients.

Bakhtadze E; Cervin C; Lindholm E; Borg H; Nilsson P; Arnqvist HJ; Bolinder J; Eriksson JW; Gudbjörnsdottir S; Nyström L; Agardh C-D; Landin-Olsson M; Sundkvist G; Groop LC
Article: JOURNAL OF INTERNAL MEDICINE. 2008;263(4):386-394

Gender differences and temporal variation in the incidence of type 1 diabetes: results of 8012 cases in the nationwide Diabetes Incidence Study in Sweden 1983-2002.

Ostman J; Lönnberg G; Arnqvist HJ; Blohmé G; Bolinder J; Ekbom Schnell A; Eriksson JW; Gudbjörnsdottir S; Sundkvist G; Nyström L
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2008;93(1):240-246

Catecholamine regulation of local lactate production in vivo in skeletal muscle and adipose tissue: role of -adrenoreceptor subtypes.

Qvisth V; Hagström-Toft E; Enoksson S; Bolinder J
Article: PHARMACEUTICAL RESEARCH. 2007;24(5):1014-1025

AAPS-FDA workshop white paper: microdialysis principles, application and regulatory perspectives.

Chaurasia CS; Müller M; Bashaw ED; Benfeldt E; Bolinder J; Bullock R; Bungay PM; DeLange ECM; Derendorf H; Elmquist WF; Hammarlund-Udenaes M; Joukhadar C; Kellogg DL; Lunte CE; Nordstrom CH; Rollema H; Sawchuk RJ; Cheung BWY; Shah VP; Stahle L; Ungerstedt U; Welty DF; Yeo H
Article: JOURNAL OF CLINICAL PHARMACOLOGY. 2007;47(5):589-603

AAPS-FDA Workshop White Paper: microdialysis principles, application, and regulatory perspectives.

Chaurasia CS; Müller M; Bashaw ED; Benfeldt E; Bolinder J; Bullock R; Bungay PM; DeLange ECM; Derendorf H; Elmquist WF; Hammarlund-Udenaes M; Joukhadar C; Kellogg DL; Lunte CE; Nordstrom CH; Rollema H; Sawchuk RJ; Cheung BWY; Shah VP; Stahle L; Ungerstedt U; Welty DF; Yeo H
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2007;292(3):E709-E714

Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women.

Qvisth V; Hagström-Toft E; Moberg E; Sjöberg S; Bolinder J
Article: AAPS JOURNAL. 2007;9(1):E48-E59

AAPS-FDA workshop white paper:: Microdialysis principles, application, and regulatory perspectives report from the joint AAPS-FDA workshop, November 4-5, 2005, Nashville, TN

Chaurasia CS; Mueller M; Bashaw ED; Benfeldt E; Bolinder J; Bullock R; Bungay PM; DeLange ECM; Derendorf H; Elmquist WF; Hammarlund-Udenaes M; Joukhadar C; Kellogg DLJ; Lunte CE; Nordstrom CH; Rollema H; Sawchuk RJ; Cheung BWY; Shah VP; Stahle L; Ungerstedt U; Welty DF; Yeo H
Article: DIABETES CARE. 2007;30(1):71-76

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.

Ekberg K; Brismar T; Johansson B-L; Lindström P; Juntti-Berggren L; Norrby A; Berne C; Arnqvist HJ; Bolinder J; Wahren J
Article: DIABETES CARE. 2006;29(12):2730-2732

Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring.

Deiss D; Bolinder J; Riveline J-P; Battelino T; Bosi E; Tubiana-Rufi N; Kerr D; Phillip M
Article: DIABETOLOGIA. 2006;49(12):2847-2852

Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS).

Littorin B; Blom P; Schölin A; Arnqvist HJ; Blohmé G; Bolinder J; Ekbom-Schnell A; Eriksson JW; Gudbjörnsdottir S; Nyström L; Ostman J; Sundkvist G
Article: DIABETOLOGIA. 2006;49(8):1785-1794

HLA-DQB1 genotypes, islet antibodies and beta cell function in the classification of recent-onset diabetes among young adults in the nationwide Diabetes Incidence Study in Sweden.

Bakhtadze E; Borg H; Stenström G; Fernlund P; Arnqvist HJ; Ekbom-Schnell A; Bolinder J; Eriksson JW; Gudbjörnsdottir S; Nyström L; Groop LC; Sundkvist G
Article: DIABETOLOGIA. 2006;49(4):653-659

Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in Sweden.

Waernbaum I; Blohmé G; Ostman J; Sundkvist G; Eriksson JW; Arnqvist HJ; Bolinder J; Nyström L
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2006;91(2):665-670

Human skeletal muscle lipolysis is more responsive to epinephrine than to norepinephrine stimulation in vivo.

Qvisth V; Hagström-Toft E; Enoksson S; Moberg E; Arner P; Bolinder J
Article: DIABETOLOGIA. 2005;48(5):946-953

Major differences in noradrenaline action on lipolysis and blood flow rates in skeletal muscle and adipose tissue in vivo.

Quisth V; Enoksson S; Blaak E; Hagström-Toft E; Arner P; Bolinder J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2005;90(2):1189-1195

Marked reutilization of free fatty acids during activated lipolysis in human skeletal muscle.

Enoksson S; Hagström-Toft E; Nordahl J; Hultenby K; Pettersson N; Isaksson B; Permert J; Wibom R; Holm C; Bolinder J; Arner P
Article: SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION. 2005;65(7):585-594

Hyperproinsulinemia segregates young adult patients with newly diagnosed autoimmune (type 1) and non-autoimmune (type 2) diabetes.

Bolinder J; Fernlund P; Borg H; Arnqvist HJ; Björk E; Blohmé G; Eriksson JW; Nyström L; Ostman J; Sundkvist G
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2004;89(9):4693-4700

Combined hyperinsulinemia and hyperglycemia, but not hyperinsulinemia alone, suppress human skeletal muscle lipolytic activity in vivo.

Qvisth V; Hagström-Toft E; Enoksson S; Sherwin RS; Sjöberg S; Bolinder J
Article: DIABETIC MEDICINE. 2004;21(5):447-455

Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes.

Schölin A; Törn C; Nyström L; Berne C; Arnqvist H; Blohmé G; Bolinder J; Eriksson JW; Kockum I; Landin-Olsson M; Ostman J; Karlsson FA; Sundkvist G; Björk E
Article: CLINICAL THERAPEUTICS. 2004;26(5):724-736

Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

Russell-Jones D; Simpson R; Hylleberg B; Draeger E; Bolinder J
Article: JOURNAL OF INTERNAL MEDICINE. 2004;255(3):384-391

Islet antibodies and remaining beta-cell function 8 years after diagnosis of diabetes in young adults: a prospective follow-up of the nationwide Diabetes Incidence Study in Sweden.

Schölin A; Björklund L; Borg H; Arnqvist H; Björk E; Blohmé G; Bolinder J; Eriksson JW; Gudbjörnsdottir S; Nyström L; Ostman J; Karlsson AF; Sundkvist G; Diabetes Incidence Study in Sweden
Article: DIABETES CARE. 2003;26(10):2903-2909

Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

Svensson M; Sundkvist G; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Henricsson M; Nyström L; Torffvit O; Waernbaum I; Ostman J; Eriksson JW; Diabetes Incidence Study in Sweden (DISS)
Article: JOURNAL OF INTERNAL MEDICINE. 2003;254(3):251-256

Increasing body mass index at diagnosis of diabetes in young adult people during 1983-1999 in the Diabetes Incidence Study in Sweden (DISS).

Littorin B; Nyström L; Gullberg B; Råstam L; Ostman J; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Eriksson JW; Scherstén B; Sundkvist G
Article: DIABETOLOGIA. 2003;46(2):173-181

Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS).

Borg H; Arnqvist HJ; Björk E; Bolinder J; Eriksson JW; Nyström L; Jeppsson J-O; Sundkvist G
Article: DIABETES CARE. 2003;26(2):349-354

The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).

Henricsson M; Nyström L; Blohmé G; Ostman J; Kullberg C; Svensson M; Schölin A; Arnqvist HJ; Björk E; Bolinder J; Eriksson JW; Sundkvist G
Article: DIABETES. 2002;51(12):3376-3383

Marked heterogeneity of human skeletal muscle lipolysis at rest.

Hagström-Toft E; Qvisth V; Nennesmo I; Rydén M; Bolinder H; Enoksson S; Bolinder J; Arner P
Article: JOURNAL OF INTERNAL MEDICINE. 2002;252(4):342-351

Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes.

Sjöberg S; Ahrén B; Bolinder J
Article: AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM. 2002;283(2):E295-E301

No apparent suppression by insulin of in vivo skeletal muscle lipolysis in nonobese women.

Moberg E; Sjöberg S; Hagström-Toft E; Bolinder J
Article: DIABETOLOGIA. 2002;45(6):783-791

The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998.

Pundziute-Lyckå A; Dahlquist G; Nyström L; Arnqvist H; Björk E; Blohmé G; Bolinder J; Eriksson JW; Sundkvist G; Ostman J; Swedish Childhood Diabetes Study Group
Article: DIABETES. 2001;50(7):1604-1611

Evidence for a major role of skeletal muscle lipolysis in the regulation of lipid oxidation during caloric restriction in vivo.

Hagström-Toft E; Thörne A; Reynisdottir S; Moberg E; Rössner S; Bolinder J; Arner P
Article: DIABETES CARE. 2001;24(6):1033-1037

Family characteristics and life events before the onset of autoimmune type 1 diabetes in young adults: a nationwide study.

Littorin B; Sundkvist G; Nyström L; Carlson A; Landin-Olsson M; Ostman J; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Eriksson JW; Scherstén B; Wibell L; Diabetes Incidence Study in Sweden (DISS)
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 2001;86(3):1229-1234

Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo.

Bertin E; Arner P; Bolinder J; Hagström-Toft E
Article: AUTOIMMUNITY. 2001;33(2):115-120

Combinations of beta cell specific autoantibodies at diagnosis of diabetes in young adults reflects different courses of beta cell damage.

Törn C; Landin-Olsson M; Lernmark A; Scherstén B; Ostman J; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G
Article: JOURNAL OF INTERNAL MEDICINE. 2000;248(5):387-396

Direct medical costs for patients with type 2 diabetes in Sweden.

Henriksson F; Agardh CD; Berne C; Bolinder J; Lönnqvist F; Stenström P; Ostenson CG; Jönsson B
Article: DIABETES-METABOLISM RESEARCH AND REVIEWS. 2000;16(6):442-447

Glutamic acid decarboxylase antibodies (GADA) is the most important factor for prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds.

Törn C; Landin-Olsson M; Ostman J; Scherstén B; Arnqvist H; Blohmé G; Björk E; Bolinder J; Eriksson J; Littorin B; Nyström L; Sundkvist G; Lernmark A
Article: CLINICAL TRANSPLANTATION. 2000;14(5):505-508

Combined pancreas and kidney transplantation improves survival in patients with end-stage diabetic nephropathy.

Tydén G; Tollemar J; Bolinder J
Article: DIABETES. 2000;49(5):797-802

Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects.

Bolinder J; Kerckhoffs DA; Moberg E; Hagström-Toft E; Arner P
Article: DIABETIC MEDICINE. 2000;17(4):269-274

Ketoacidosis in young adults is not related to the islet antibodies at the diagnosis of Type 1 diabetes mellitus--a nationwide study.

Ostman J; Landin-Olsson M; Törn C; Palmer J; Lernmark A; Arnqvist H; Björk E; Bolinder J; Blohmé G; Eriksson J; Littorin B; Nyström L; Scherstén B; Sundkvist G; Wibell L
Article: DIABETIC MEDICINE. 1999;16(10):827-834

The role of sulphonylurea in combination therapy assessed in a trial of sulphonylurea withdrawal. Scandinavian Insulin-Sulphonylurea Study Group Research Team.

Landstedt-Hallin L; Arner P; Lins PE; Bolinder J; Olsen H; Groop L
Article: TRANSPLANTATION. 1999;67(5):645-648

Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation.

Tydén G; Bolinder J; Solders G; Brattström C; Tibell A; Groth CG
Article: DIABETES CARE. 1999;22(3):409-412

Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment. A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes.

Littorin B; Sundkvist G; Hagopian W; Landin-Olsson M; Lernmark A; Ostman J; Arnqvist HJ; Blohmé G; Bolinder J; Eriksson JW; Lithner F; Scherstén B; Wibell L
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1998;275(6):E909-E916

beta-Adrenergic regulation of lipolysis and blood flow in human skeletal muscle in vivo.

Hagström-Toft E; Enoksson S; Moberg E; Bolinder J; Arner P
Article: DIABETOLOGIA. 1998;41(11):1343-1354

Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.

Zierath JR; Livingston JN; Thörne A; Bolinder J; Reynisdottir S; Lönnqvist F; Arner P
Article: CLINICAL SCIENCE. 1998;94(1):71-77

Lipolysis and lactate production in human skeletal muscle and adipose tissue following glucose ingestion.

Kerckhoffs DA; Arner P; Bolinder J
Article: DIABETOLOGIA. 1997;40(11):1320-1326

Protracted glucose fall in subcutaneous adipose tissue and skeletal muscle compared with blood during insulin-induced hypoglycaemia.

Moberg E; Hagström-Toft E; Arner P; Bolinder J
Article: DIABETES CARE. 1997;20(10):1594-1597

Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group.

Oskarsson P; Ljunggren JG; Lins PE
Article: HORMONE AND METABOLIC RESEARCH. 1997;29(9):440-443

Detection of hypoglycaemia by microdialysis measurements of glucose in subcutaneous adipose tissue.

Moberg E; Hagström-Toft E; Bolinder J
Article: AMERICAN JOURNAL OF PHYSIOLOGY. 1997;273(3 Pt 1):E584-E592

Absolute concentrations of glycerol and lactate in human skeletal muscle, adipose tissue, and blood.

Hagström-Toft E; Enoksson S; Moberg E; Bolinder J; Arner P
Article: DIABETOLOGIA. 1997;40(9):1070-1078

A circadian rhythm in lipid mobilization which is altered in IDDM.

Hagström-Toft E; Bolinder J; Ungerstedt U; Arner P
Article: ACTA DIABETOLOGICA. 1997;34(1):10-17

Short-term treatment with ramipril normalizes renal haemodynamics and the natriuretic response to a sodium load in type 1 diabetic patients with early nephropathy.

Stenvinkel P; Bolinder J; Alvestrand A
Article: DIABETES CARE. 1997;20(1):64-70

Self-monitoring of blood glucose in type I diabetic patients: comparison with continuous microdialysis measurements of glucose in subcutaneous adipose tissue during ordinary life conditions.

Bolinder J; Hagström-Toft E; Ungerstedt U; Arner P
Article: NEW ENGLAND JOURNAL OF MEDICINE. 1996;335(12):860-863

Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts.

Tydén G; Reinholt FP; Sundkvist G; Bolinder J
Article: NUTRITION. 1996;12(9):589-594

Carbohydrate three-carbon metabolism of adipose tissue during surgery.

Felländer G; Bolinder J; Ungerstedt U; Arner P; Tjäder I; Nordenström J
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1996;81(8):2919-2924

Microdialysis of adipose tissue during surgery: effect of local alpha- and beta-adrenoceptor blockade on blood flow and lipolysis.

Felländer G; Eleborg L; Bolinder J; Nordenström J; Arner P
Article: DIABETOLOGIA. 1996;39(7):845-853

Stimulation of adipose tissue lipolysis following insulin-induced hypoglycaemia: evidence of increased beta-adrenoceptor-mediated lipolytic response in IDDM.

Bolinder J; Sjöberg S; Arner P
Article: INTERNATIONAL JOURNAL OF OBESITY. 1996;20(3):220-226

Evaluation of the microdialysis ethanol technique for monitoring of subcutaneous adipose tissue blood flow in humans.

Felländer G; Linde B; Bolinder J
Article: ACTA DIABETOLOGICA. 1995;32(4):230-234

Effect of insulin on renal sodium handling and renal haemodynamics in insulin-dependent (type 1) diabetes mellitus patients.

Stenvinkel P; Ottosson-Seeberger A; Alvestrand A; Bolinder J
Article: DIABETES. 1995;44(10):1170-1175

Role of phosphodiesterase III in the antilipolytic effect of insulin in vivo.

Hagström-Toft E; Bolinder J; Eriksson S; Arner P
Show more

All other publications

Published conference paper: DIABETES TECHNOLOGY & THERAPEUTICS. 2020;22(S1):S32-S46

New Insulins, Biosimilars, and Insulin Therapy.

Danne T; Heinemann L; Bolinder J
Letter: DIABETOLOGIA. 2018;61(8):1879-1880

Flash glucose monitoring: objective, not self-referential, outcomes are needed. Reply to Warren RE [letter].

Bolinder J; Oskarsson P; Antuna R; Geelhoed-Duijvestijn P; Krӧger J; Weitgasser R
Letter: LANCET. 2017;389(10077):1396-1397

Cutaneous adverse events related to FreeStyle Libre device - Authors' reply.

Bolinder J; Antuna R; Geelhoed-Duijvestijn P; Kröger J; Weitgasser R
Corrigendum: DIABETOLOGIA. 2006;49(6):1457

Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis:: a population-based study (DISS) in Sweden (vol 49, pg 1131, 2006)

Waernbaum I; Blohmé G; Ötman J; Sundkvist G; Eriksson JW; Arnqvist HJ; Bolinder J; Nyström L
Corrigendum: DIABETOLOGIA. 2004;47(1):154

Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS) (vol 46, pg 173, 2003)

Borg H; Arnqvist HJ; Björk E; Bolinder J; Eriksson JW; Nyström L; Jeppsson JO; Sundkvist G
Letter: DIABETOLOGIA. 2002;45(7):1043-1044

Autonomic neuropathy is associated with impaired pancreatic polypeptide and neuropeptide Y responses to insulin-induced hypoglycaemia in Type I diabetic patients.

Bolinder J; Sjöberg S; Persson A; Ahrén B; Sundkvist G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 2001;33(4):2535-2536

Experience with human islet transplantation in Sweden.

Tibell A; Bolinder J; Hagström-Toft E; Tollemar J; Brendel M; Eckhard M; Brandhorst D; Bretzel RG; Korsgren O; Groth C
Meeting abstract: TRANSPLANTATION. 1999;67(7):S223

Ten-year results with pancreatic transplantation:: Persistent normoglycemia and superior patient survival

Tydén G; Bolinder J; Brattström C; Groth CG
Letter: DIABETOLOGIA. 1998;41(12):1532-1533

Islet autoimmunity before and after pancreas transplantation in patients with Type I diabetes mellitus.

Sundkvist G; Tydén G; Karlsson FA; Bolinder J
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1998;30(7):3413

Diabetic patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone: outcome after 5 to 10 years.

Groth CG; Bolinder J; Solders G; Brattström C; Tibell A; Tydén G
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1998;30(2):634

Long-term metabolic control in recipients of segmental or whole-organ pancreatic grafts with enteric exocrine diversion and function beyond 5 years.

Tyden G; Bolinder J; Brattström C; Tibell A; Grott CG
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1998;30(2):332

A 10 year prospective study of IDDM patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone.

Tydén G; Bolinder J; Solders G; Nakache R; Brattström C; Tibell A; Groth CG
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3124-3125

Early experience with a long-distance collaborative human islet transplant programme.

Tibell A; Brendel M; Wadström J; Brandhorst D; Brandhorst H; Eckhard M; Bolinder J; Bretzel RG; Groth CG
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1997;29(7):3119

A 10-year prospective study of IDDM patients subjected to combined pancreas and kidney transplantation or kidney transplantation alone.

Tydén G; Bolinder J; Solders G; Nakache R; Brattström C; Tibell A; Groth CG
Letter: DIABETES CARE. 1997;20(7):1209

Self-monitoring of blood glucose compared with continuous tissue glucose measurement - Response to Sternberg et al.

Bolinder J; HagstromToft E; Arner P
Editorial comment: DIABETES, NUTRITION AND METABOLISM - CLINICAL AND EXPERIMENTAL. 1996;9(1):33-50

Hypoglycaemia warning on the basis of intracorporal glucose monitoring

Fischer U; Bendtson I; Bolinder J; Reach G; Guy RH
Published conference paper: TRANSPLANTATION PROCEEDINGS. 1995;27(6):3029-3030

Metabolic control in recipients of segmental pancreatic grafts functioning beyond 8 years.

Tibell A; Tydén G; Bolinder J; Larsson M; Groth CG
Other: DIABETES CARE. 1995;18(8):1183-1186

Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure.

Landstedt-Hallin L; Adamson U; Arner P; Bolinder J; Lins PE
Other: INTERNATIONAL JOURNAL OF OBESITY. 1995;19(5):350-354

Influence of local blood flow on glycerol levels in human adipose tissue.

Enoksson S; Nordenström J; Bolinder J; Arner P

About me

Research

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI